- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03834480
Intraartecular Platelet Rich Plasma for Sacroiliitis
Ultra Sound Guided Injection of Platelet Rich Plasma Versus Steroid for Sacroiliac Joint Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A prospective randomized controlled study was conducted at the department of anesthesiology Mansoura University Hospital during the period from December 2017 to January 2019 on fifty ASA I-III adult patients, of both sex after approval of IRB (Institutional Review Board) ID number MS17.10.03 & IRB date 12-11-2017. The patients were randomly allocated into two groups each of 25 patients according to computer-generated random number codes that were placed in sealed envelopes, double blinded, with parallel-group comparison.
Steroid Group (S) (n. 25):- Patients were injected by 4 ml of sterile water containing the methylprednisolone Acetate (Depo-Medrol) per-kg calculated dose (0.5mg/kg up to a lean muscle body weight of 80kg in the painful sacroiliac joint).
Platelet rich plasma Group (P) (n. 25):-Patients received fixed volume of 4 ml platelet-rich plasma in the inflamed painful sacroiliac joint.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Dakahlia
-
Mansourah, Dakahlia, Egypt
- Mansoura faculty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
1. Patients of either sex. 2. ASA I&III. 3. Age between 18 - 70 years. 4. Chronic lower back pain of sacroiliac origin. 5. Anatomy of the joint can identified by the ultrasonography. Exclusion criteria
- Patients with contraindications to sacroiliac injection.
- Patients known to be allergic to platelet rich plasma or local anesthetics.
- History of immune suppression or immune compromised diseases
- Patient below age of 18 as the joint will undergo normal physiological changes.
- Patient over 70 years.
- Sacroiliac pain of multiple sources.
- Preoperative shivering or fever (>38oc).
- Hepatic, renal and heart failure patients.
- Patients on; anticoagulants, antiplatelet, and with INR≥1.5.
- Exclude corticosteroid injection in the sacroiliac joint at the last three months.
- Patient refusal.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: • Steroid Group (S)
|
At the level of the sacral hiatus, the sacral cornuae were identified.
posterior aspect of the sacroiliac joint, at 4.5 cm depth the SIJ was found.
localal anesthetic was injected at the medial edge of the transducer, the spinal needle was advanced in a medial to lateral direction, under direct vision, until the needle was positioned in the SIJ.
Local steroid solution or PRP 4ml volume was injected according to the study group and patient enrollment.
If the injection is extra-articular, injectate (hyperechoic solution as it contains particulate steroid) can be seen spreading medially over the sacrum.
The visual analog score, Oswestry Disability Index (ODI) score and the overall success rate basal, after one week,after one month,after three and six month's follow-up period after the initial block.
|
Experimental: • Platelet rich plasma Group (PRP)
|
At the level of the sacral hiatus, the sacral cornuae were identified.
posterior aspect of the sacroiliac joint, at 4.5 cm depth the SIJ was found.
localal anesthetic was injected at the medial edge of the transducer, the spinal needle was advanced in a medial to lateral direction, under direct vision, until the needle was positioned in the SIJ.
Local steroid solution or PRP 4ml volume was injected according to the study group and patient enrollment.
If the injection is extra-articular, injectate (hyperechoic solution as it contains particulate steroid) can be seen spreading medially over the sacrum.
The visual analog score, Oswestry Disability Index (ODI) score and the overall success rate basal, after one week,after one month,after three and six month's follow-up period after the initial block.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual analog score
Time Frame: Basal and after 6 months
|
To evaluate the changes in visual analogue score over a 6-month follow-up period after intra-articular injection and compare these changes among the studied groups.
|
Basal and after 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MS17.10.03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sacroiliitis
-
Tenon MedicalRecruitingSacroiliac Joint Disruption | Degenerative SacroiliitisUnited States
-
Tenon MedicalEnrolling by invitationSacroiliac Joint Disruption | Degenerative SacroiliitisUnited States
-
SI-BONE, Inc.CompletedSacroiliac Joint Disruption | Degenerative SacroiliitisUnited States
-
SI-BONE, Inc.CompletedSacroiliac Joint Disruption | Degenerative SacroiliitisUnited States
-
Karim Alaaeldin TawfikCompleted
-
University Hospital, MontpellierEuropean Regional Development Fund; DMS Apelem; BPIfrance; Thales; Digisens; MedecomUnknown
-
United States Naval Medical Center, San DiegoUnited States Naval Medical Center, PortsmouthCompletedSacroiliitisUnited States
-
Tanta UniversityRecruitingthe Efficacy of Ultrasound Guided Sacroiliac Injection of Ozone, Platelet Rich Plasma (PRP) or Steroid for Treatment of SacroiliitisEgypt
-
Mansoura UniversityRecruitingSacroiliac Joint ArthritisEgypt
-
FUSMobile Inc.Sheba Medical CenterRecruiting
Clinical Trials on Ultrasound guided Sacroiliac intra-articular injection
-
Diskapi Teaching and Research HospitalCompleted
-
Sohag UniversityNot yet recruiting
-
Istanbul UniversityRecruiting
-
Dalia Salah SaifUnknownRA - Rheumatoid ArthritisEgypt
-
CornerLocTerminatedSacroiliac Joint Somatic DysfunctionUnited States
-
St George's, University of LondonWellcome Trust; Rosetrees TrustUnknownRheumatoid Arthritis | Osteoarthritis, Knee | Psoriatic Arthritis | SpondyloarthritisUnited Kingdom
-
Istanbul UniversityNot yet recruitingShoulder Pain | Shoulder Capsulitis | Frozen Shoulder
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
University Hospital TuebingenUnknownJuvenile Idiopathic ArthritisGermany
-
University of UtahRadiological Society of North AmericaRecruitingLow Back Pain | Sacroiliac Joint SynovitisUnited States